Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
European journal of inflammation / / University of Chieti, Italy
| European journal of inflammation / / University of Chieti, Italy |
| Pubbl/distr/stampa | Silvi Marina (TE), Italy, : Biolife, ©2003- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Inflammation
Anti-inflammatory agents Immunotherapy Anti-Inflammatory Agents - therapeutic use |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 2058-7392 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910228952803321 |
| Silvi Marina (TE), Italy, : Biolife, ©2003- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Frontiers in clinical drug research - anti infectives . Volume 5 / / edited by Atta-ur-Rahman
| Frontiers in clinical drug research - anti infectives . Volume 5 / / edited by Atta-ur-Rahman |
| Pubbl/distr/stampa | Sharjah, U.A.E : , : Bentham Books, , [2019] |
| Descrizione fisica | 1 online resource (246 pages) |
| Disciplina | 615.7 |
| Soggetto topico | Anti-inflammatory agents |
| ISBN | 1-68108-637-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910793763703321 |
| Sharjah, U.A.E : , : Bentham Books, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Frontiers in clinical drug research - anti infectives . Volume 5 / / edited by Atta-ur-Rahman
| Frontiers in clinical drug research - anti infectives . Volume 5 / / edited by Atta-ur-Rahman |
| Pubbl/distr/stampa | Sharjah, U.A.E : , : Bentham Books, , [2019] |
| Descrizione fisica | 1 online resource (246 pages) |
| Disciplina | 615.7 |
| Soggetto topico | Anti-inflammatory agents |
| ISBN | 1-68108-637-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910816432103321 |
| Sharjah, U.A.E : , : Bentham Books, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Frontiers in clinical drug research - anti-allergy agents . Volume 4 / / edited by Atta-ur-Rahman
| Frontiers in clinical drug research - anti-allergy agents . Volume 4 / / edited by Atta-ur-Rahman |
| Pubbl/distr/stampa | Singapore : , : Bentham Science Publishers Pte. Ltd., , [2020] |
| Descrizione fisica | 1 online resource (175 pages) |
| Disciplina | 615.7 |
| Soggetto topico |
Antiallergic agents
Anti-inflammatory agents |
| ISBN | 981-14-2839-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910794494903321 |
| Singapore : , : Bentham Science Publishers Pte. Ltd., , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Frontiers in clinical drug research - anti-allergy agents . Volume 4 / / edited by Atta-ur-Rahman
| Frontiers in clinical drug research - anti-allergy agents . Volume 4 / / edited by Atta-ur-Rahman |
| Pubbl/distr/stampa | Singapore : , : Bentham Science Publishers Pte. Ltd., , [2020] |
| Descrizione fisica | 1 online resource (175 pages) |
| Disciplina | 615.7 |
| Soggetto topico |
Antiallergic agents
Anti-inflammatory agents |
| ISBN | 981-14-2839-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910818722303321 |
| Singapore : , : Bentham Science Publishers Pte. Ltd., , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Inflammation and Allergy Drug Design
| Inflammation and Allergy Drug Design |
| Autore | Izuhara K |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Chicester, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (346 p.) |
| Disciplina |
615.7
615.794 615/.7 |
| Altri autori (Persone) |
HolgateStephen T
Wills-KarpMarsha |
| Soggetto topico |
Allergy - Treatment
Allergy -- Treatment Antiallergic agents Anti-Allergic Agents Anti-Inflammatory Agents Anti-inflammatory agents Drug Design Drugs - Design Drugs -- Design Hypersensitivity - drug therapy Hypersensitivity -- drug therapy Antiallergic agents - Treatment Allergy - Design Drugs Drug Discovery Therapeutics Immune System Diseases Therapeutic Uses Diseases Pharmacologic Actions Investigative Techniques Chemistry, Pharmaceutical Chemical Actions and Uses Pharmacology Chemistry Biological Science Disciplines Natural Science Disciplines Drug Therapy Hypersensitivity Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-283-20493-2
9786613204936 1-4443-4668-7 1-4443-4666-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Inflammation and Allergy Drug Design; Contents; Contributors; Preface; Part I: Cells contributing to the pathogenesis of allergic diseases in the respiratory tract; 1: Novel anti-inflammatory drugs based on targeting lung dendritic cells and airway epithelial cells; 2: Role of Th2 cells in the allergic diathesis; 3: Importance of Th17-and Th1-associated responses for the development of asthma; 4: Regulatory T cells; 5: A role for natural killer T-cell subsets in the pathogenesis of various allergic disorders; 6: Regulatory roles of B cells in allergy and inflammation; 7: Mast cells
8: Eosinophils9: Basophils in inflammation and allergy drug design; 10: Epithelial cells; 11: Fibroblasts; 12: Airway smooth muscle cells; Part II: Cytokines contributing to the pathogenesis of allergic diseases in the respiratory tract; 13: Interleukin 4, interleukin 13, and interleukin 9; 14: Interleukin 3, interleukin 5, and granulocyte-macrophage colony-stimulating factor; 15: Interleukin 15, interleukin 17, and interleukin 25; 16: Thymic stromal lymphopoietin; 17: Interleukin 10; 18: Tumor necrosis factor alpha; 19: Profibrotic and angiogenic factors in asthma; 20: Chemokines 21: Epithelial growth factorsPart III: Other mediators contributing to the pathogenesis of allergic diseases in the respiratory tract; 22: Prostanoids; 23: Leukotrienes; 24: Proteases in allergy; 25: Toll-like receptors; Index |
| Record Nr. | UNINA-9910139614403321 |
Izuhara K
|
||
| Chicester, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Inflammopharmacology
| Inflammopharmacology |
| Pubbl/distr/stampa | Dordrecht, the Netherlands ; ; Norwell, MA, USA, : Kluwer Academic Publishers, ©1991- |
| Disciplina | 616.0473 |
| Soggetto topico |
Anti-inflammatory agents
Inflammation Anti-Inflammatory Agents - therapeutic use Inflammation - drug therapy Immunology Pharmacology |
| Soggetto genere / forma | Periodicals. |
| Soggetto non controllato | Humans - Inflammatory diseases |
| ISSN | 1568-5608 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Inflammo pharmacology |
| Record Nr. | UNINA-9910140290303321 |
| Dordrecht, the Netherlands ; ; Norwell, MA, USA, : Kluwer Academic Publishers, ©1991- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Inflammopharmacology
| Inflammopharmacology |
| Pubbl/distr/stampa | Dordrecht, the Netherlands ; ; Norwell, MA, USA, : Kluwer Academic Publishers, ©1991- |
| Disciplina | 616.0473 |
| Soggetto topico |
Anti-inflammatory agents
Inflammation Anti-Inflammatory Agents - therapeutic use Inflammation - drug therapy Immunology Pharmacology |
| Soggetto genere / forma | Periodicals. |
| Soggetto non controllato | Humans - Inflammatory diseases |
| ISSN | 1568-5608 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Inflammo pharmacology |
| Record Nr. | UNISA-996212159903316 |
| Dordrecht, the Netherlands ; ; Norwell, MA, USA, : Kluwer Academic Publishers, ©1991- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Infliximab [[electronic resource] ] : pharmacology, uses and limitations / / Antonio D. Medrano Acevedo and Montserrat Fajardo Gaitan, editors
| Infliximab [[electronic resource] ] : pharmacology, uses and limitations / / Antonio D. Medrano Acevedo and Montserrat Fajardo Gaitan, editors |
| Pubbl/distr/stampa | New York, : Nova Science Publishers, c2012 |
| Descrizione fisica | 1 online resource (204 p.) |
| Disciplina | 615.7/94 |
| Altri autori (Persone) |
Fajardo GaitanMontserrat
Medrano AcevedoAntonio D |
| Collana | Immunology and immune system disorders |
| Soggetto topico |
Anti-inflammatory agents
Infliximab - Therapeutic use Infliximab |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61942-345-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""Contents ""; ""Preface ""; ""The Risk of Infection in Patients Treated with Infliximab ""; ""Abstract ""; ""1. Definition and Functions of Tumour Necrosis Factor ""; ""2. Anti-TNF Mechanism of Action: Infliximab ""; ""3. Risk of Infections in the Use of Infliximab: Evidence""; ""4. Risk of Infection from the Use of Anti-TNF (Inflximab): Mechanisms Involved""; ""5. Other Risk Factors for Infection in Patients Treated with Infliximab ""; ""6. Infections ""; ""Bacterial Infections""
""Listeria """"Tuberculosis ""; ""Virus ""; ""Fungal Infections ""; ""Histoplasmosis ""; ""Coccidioidomycosis ""; ""Cryptococcosis ""; ""Aspergillosis ""; ""Candidiasis""; ""Pneumocystosis ""; ""7. Special Situations""; ""Perisurgical Infections ""; ""Hepatitis B Virus Infection ""; ""Hepatitis C Virus Infection ""; ""HIV Infection ""; ""Vaccines ""; ""Conclusions ""; ""References ""; ""Infliximab in Inflammatory Bowel Disease ""; ""Abstract ""; ""Pharmacology""; ""Uses ""; ""Inflammatory Crohn�s Disease ""; ""Fistulizing Crohn�s Disease ""; ""Ulcerative Colitis""; ""Mucosal Healing "" ""Pouchitis""""Extraintestinal Manifestations ""; ""Limitations ""; ""Predictors of Response to Infliximab ""; ""Infections ""; ""Malignancies and Lymphoma ""; ""Cutaneous, Neurological and Liver Manifestations ""; ""Congestive Heart Failure ""; ""Pregnancy ""; ""References ""; ""Infliximab: Up-to-Date on Indications and Warnings ""; ""Abstract ""; ""1. Introduction""; ""2. Pharmacology""; ""2.1. Structure and Mechanisms of Action""; ""2.2. Absorption ""; ""2.3. Distribution ""; ""2.4. Metabolism and Excretion ""; ""2.5. Dosage and Administration ""; ""2.6. Pharmacogenomics"" ""D) Chronic Eczema """"E) Hidradenitis Susppurativa (HS) ""; ""3.3. Other Verified Uses ""; ""a) SAPHO Syndrome ""; ""b) Kawasaki Disease ""; ""c) Pulmonary Fibrosis ""; ""d) Cap Polyposis ""; ""e) Postresuscitation Myocardial Dysfunction ""; ""f) B-Chronic Lymphocytic Leukemia ""; ""g) Diabetic Macular Edema ""; ""4. Warnings and Limitations""; ""4.1. Serious Infections ""; ""4.2. Malignancies ""; ""4.3. Hepatitis B virus Reactivation ""; ""4.4. Hepatotoxicity ""; ""4.5. Patients with Heart Failure ""; ""4.6. Hematological and Vascular Events ""; ""4.7. Hypersensitivity "" ""4.8. Neurological Events "" |
| Record Nr. | UNINA-9910452691503321 |
| New York, : Nova Science Publishers, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Infliximab [[electronic resource] ] : pharmacology, uses and limitations / / Antonio D. Medrano Acevedo and Montserrat Fajardo Gaitan, editors
| Infliximab [[electronic resource] ] : pharmacology, uses and limitations / / Antonio D. Medrano Acevedo and Montserrat Fajardo Gaitan, editors |
| Pubbl/distr/stampa | New York, : Nova Science Publishers, c2012 |
| Descrizione fisica | 1 online resource (204 p.) |
| Disciplina | 615.7/94 |
| Altri autori (Persone) |
Fajardo GaitanMontserrat
Medrano AcevedoAntonio D |
| Collana | Immunology and immune system disorders |
| Soggetto topico |
Anti-inflammatory agents
Infliximab - Therapeutic use Infliximab |
| ISBN | 1-61942-345-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""Contents ""; ""Preface ""; ""The Risk of Infection in Patients Treated with Infliximab ""; ""Abstract ""; ""1. Definition and Functions of Tumour Necrosis Factor ""; ""2. Anti-TNF Mechanism of Action: Infliximab ""; ""3. Risk of Infections in the Use of Infliximab: Evidence""; ""4. Risk of Infection from the Use of Anti-TNF (Inflximab): Mechanisms Involved""; ""5. Other Risk Factors for Infection in Patients Treated with Infliximab ""; ""6. Infections ""; ""Bacterial Infections""
""Listeria """"Tuberculosis ""; ""Virus ""; ""Fungal Infections ""; ""Histoplasmosis ""; ""Coccidioidomycosis ""; ""Cryptococcosis ""; ""Aspergillosis ""; ""Candidiasis""; ""Pneumocystosis ""; ""7. Special Situations""; ""Perisurgical Infections ""; ""Hepatitis B Virus Infection ""; ""Hepatitis C Virus Infection ""; ""HIV Infection ""; ""Vaccines ""; ""Conclusions ""; ""References ""; ""Infliximab in Inflammatory Bowel Disease ""; ""Abstract ""; ""Pharmacology""; ""Uses ""; ""Inflammatory Crohn�s Disease ""; ""Fistulizing Crohn�s Disease ""; ""Ulcerative Colitis""; ""Mucosal Healing "" ""Pouchitis""""Extraintestinal Manifestations ""; ""Limitations ""; ""Predictors of Response to Infliximab ""; ""Infections ""; ""Malignancies and Lymphoma ""; ""Cutaneous, Neurological and Liver Manifestations ""; ""Congestive Heart Failure ""; ""Pregnancy ""; ""References ""; ""Infliximab: Up-to-Date on Indications and Warnings ""; ""Abstract ""; ""1. Introduction""; ""2. Pharmacology""; ""2.1. Structure and Mechanisms of Action""; ""2.2. Absorption ""; ""2.3. Distribution ""; ""2.4. Metabolism and Excretion ""; ""2.5. Dosage and Administration ""; ""2.6. Pharmacogenomics"" ""D) Chronic Eczema """"E) Hidradenitis Susppurativa (HS) ""; ""3.3. Other Verified Uses ""; ""a) SAPHO Syndrome ""; ""b) Kawasaki Disease ""; ""c) Pulmonary Fibrosis ""; ""d) Cap Polyposis ""; ""e) Postresuscitation Myocardial Dysfunction ""; ""f) B-Chronic Lymphocytic Leukemia ""; ""g) Diabetic Macular Edema ""; ""4. Warnings and Limitations""; ""4.1. Serious Infections ""; ""4.2. Malignancies ""; ""4.3. Hepatitis B virus Reactivation ""; ""4.4. Hepatotoxicity ""; ""4.5. Patients with Heart Failure ""; ""4.6. Hematological and Vascular Events ""; ""4.7. Hypersensitivity "" ""4.8. Neurological Events "" |
| Record Nr. | UNINA-9910779511503321 |
| New York, : Nova Science Publishers, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
